OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p/3p in hepatocellular carcinoma
Lin Zhou, Qing Zhang, Jiaxin Cheng, et al.
Drug Discoveries & Therapeutics (2023) Vol. 17, Iss. 4, pp. 248-256
Open Access | Times Cited: 14
Lin Zhou, Qing Zhang, Jiaxin Cheng, et al.
Drug Discoveries & Therapeutics (2023) Vol. 17, Iss. 4, pp. 248-256
Open Access | Times Cited: 14
Showing 14 citing articles:
Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease
Yutong Sui, Xue Geng, Ziwei Wang, et al.
Metabolism (2024) Vol. 157, pp. 155953-155953
Closed Access | Times Cited: 13
Yutong Sui, Xue Geng, Ziwei Wang, et al.
Metabolism (2024) Vol. 157, pp. 155953-155953
Closed Access | Times Cited: 13
Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs
Haoran Chen, Zhongyu Han, Junyan Su, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Haoran Chen, Zhongyu Han, Junyan Su, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway
Shiming Tan, Shizhen Li, Longzheng Xia, et al.
International Journal of Oncology (2025) Vol. 66, Iss. 3
Closed Access
Shiming Tan, Shizhen Li, Longzheng Xia, et al.
International Journal of Oncology (2025) Vol. 66, Iss. 3
Closed Access
LncRNA SNHG1: A novel biomarker and therapeutic target in hepatocellular carcinoma
Zhou Fang, Yong Pan, Zhengmei Lu, et al.
Gene (2025), pp. 149462-149462
Closed Access
Zhou Fang, Yong Pan, Zhengmei Lu, et al.
Gene (2025), pp. 149462-149462
Closed Access
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 766-766
Open Access | Times Cited: 2
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 766-766
Open Access | Times Cited: 2
Ferroptosis in hepatocellular carcinoma: Mechanisms and therapeutic implications
Shanjie Tu, Yisheng Zou, Meiqi Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117769-117769
Closed Access | Times Cited: 2
Shanjie Tu, Yisheng Zou, Meiqi Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117769-117769
Closed Access | Times Cited: 2
Non-coding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
(2024)
Open Access | Times Cited: 1
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
(2024)
Open Access | Times Cited: 1
The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xin Jin, C. Huang, Yue Tian
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma
Lijie Sun, Hongfei Cao, Yanzhe Wang, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Lijie Sun, Hongfei Cao, Yanzhe Wang, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
SNHG1: Redefining the Landscape of Hepatocellular Carcinoma through Long Noncoding RNAs
Tiago Fonseca, Rui Miguel Martins, Anabela P. Rolo, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1696-1696
Open Access
Tiago Fonseca, Rui Miguel Martins, Anabela P. Rolo, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1696-1696
Open Access
Emerging insights into the role of microRNAs regulation of ferroptosis in hepatocellular carcinoma
Qi Zhang, Yingdan Zhang, Shiyun Guo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167642-167642
Closed Access
Qi Zhang, Yingdan Zhang, Shiyun Guo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167642-167642
Closed Access
Targeting miR-199a reduces fibrosis in hypertrophic cardiomyopathy
Stanislovas S. Jankauskas, Fahimeh Varzideh, Urna Kansakar, et al.
Journal of Molecular and Cellular Cardiology Plus (2023) Vol. 7, pp. 100057-100057
Open Access
Stanislovas S. Jankauskas, Fahimeh Varzideh, Urna Kansakar, et al.
Journal of Molecular and Cellular Cardiology Plus (2023) Vol. 7, pp. 100057-100057
Open Access
